Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
The Lancet. Haematology|December 22, 2015
Cardiovascular disease after treatment for Hodgkin's lymphoma: an analysis of nine collaborative EORTC-LYSA trialsMaja V Maraldo, Francesco Giusti, Ivan R Vogelius, et al.
International Journal of Radiation Oncology, Biology, Physics|May 13, 2023
A Quality Control Study on Involved Node Radiation Therapy in the European Organisation for Research and Treatment of Cancer/Lymphoma Study Association/Fondazione Italiana Linfomi H10 Trial on Stages I and II Hodgkin Lymphoma: Lessons LearnedBerthe M P Aleman, Umberto Ricardi, Richard W M van der Maazen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 23, 2025
Radiotherapy quality assurance of the prospective randomised EORTC-1219/DAHANCA-29 trial: an individual case review analysisNajlaa Alyamani, André Abrunhosa-Branquinho, Coreen Corning, et al.
Cancer|October 5, 2020
Predictive classifier for intensive treatment of head and neck cancerKaveh Zakeri, Federico Rotolo, Benjamin Lacas, et al.
Cancer Medicine|July 26, 2020
Long-term overall survival and toxicities of ABVD vs BEACOPP in advanced Hodgkin lymphoma: A pooled analysis of four randomized trialsMarc P E André, Patrice Carde, Simonetta Viviani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2023
Long-Term Follow-Up of the Response-Adapted Intergroup EORTC/LYSA/FIL H10 Trial for Localized Hodgkin LymphomaMassimo Federico, Catherine Fortpied, Yana Stepanishyna, et al.
Haematologica|May 31, 2022
High-risk stage IIB Hodgkin lymphoma treated in the H10 and AHL2011 trials: total metabolic tumor volume is a useful risk factor to stratify patients at baselineCédric Rossi, Marc André, Jehan Dupuis, et al.
Frontiers in Oncology|November 8, 2019
Organ Preservation and Late Functional Outcome in Oropharyngeal Carcinoma: Rationale of EORTC 1420, the "Best of" TrialJean-Jacques Stelmes, Vincent Gregoire, Vincent Vander Poorten, et al.
The Lancet. Oncology|November 5, 2020
Internal mammary and medial supraclavicular lymph node chain irradiation in stage I-III breast cancer (EORTC 22922/10925): 15-year results of a randomised, phase 3 trialPhilip M Poortmans, Caroline Weltens, Catherine Fortpied, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 28, 2024
The EORTC 22922/10925 trial investigating regional nodal irradiation in stage I-III breast cancer: Outcomes according to locoregional and systemic therapiesOrit Kaidar-Person, Liesbeth J Boersma, Peter De Brouwer, et al.
Pageof 5